Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740839 · ClinicalTrials.gov registry record · NA
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
A NA study of Pediatric Brain Tumor, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05740839: Recruiting NA study of Pediatric Brain Tumor, sponsored by Dana-Farber Cancer Institute.
NCT05740839 is a NA study of Pediatric Brain Tumor that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 30 participants, below the 42-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05740839, a NA study of Pediatric Brain Tumor, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a 16-week virtual, home-based, high-intensity interval training (HIIT) exercise program will improve physical, cognitive, and emotional health among young adult survivors of pediatric brain tumors. The names of the study interventions involved in this study are/is: * High-Intensity Interval Training (HIIT)
Primary Outcome
Defined as participant attendance of \>= 70% of the 48 HIIT exercise sessions.
Conditions Studied
Interventions
- BEHAVIORAL HIIT Exercise Program
- BEHAVIORAL Control Group
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2027-09-24 |
| Phase | NA |
What NCT05740839 shows while recruiting
NCT05740839 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 42-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Pediatric Brain Tumor appearing as the primary indexed condition, and to 2 interventions - of which HIIT Exercise Program is the first listed.
NCT05740839 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05740839 about?
NCT05740839 is a clinical study titled "High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study". The purpose of this study is to determine whether a 16-week virtual, home-based, high-intensity interval training (HIIT) exercise program will improve physical, cognitive, and emotional health among young adult survivors of pediatric brain tumors. The names of the study interventions involved in th...
What is the current status of trial NCT05740839?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-12-04. Estimated completion is 2027-09-24.
What conditions does trial NCT05740839 study?
This clinical trial studies the following conditions: Pediatric Brain Tumor.
What interventions are being tested in trial NCT05740839?
The interventions under investigation include: HIIT Exercise Program (BEHAVIORAL), Control Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05740839?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05740839 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05740839's enrollment target sits among peer trials
30 6th of 9 higher than 3 of 9 other Pediatric Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Survivors Journey+
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
ACTIVE NOT RECRUITING · NA
-
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
RECRUITING · Phase 1
-
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
RECRUITING · Phase 1
-
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI